You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 6,426,335


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,426,335
Title: Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
Abstract:This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.
Inventor(s): Janjic; Nebojsa (Boulder, CO), Gold; Larry (Boulder, CO), Schmidt; Paul (Niwot, CO), Vargeese; Chandra (Thornton, CO), Willis; Michael (Louisville, CO)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:09/254,968
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,426,335

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,426,335

PCT Information
PCT FiledOctober 17, 1997PCT Application Number:PCT/US97/18944
PCT Publication Date:May 07, 1998PCT Publication Number: WO98/18480

International Family Members for US Patent 6,426,335

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0957929 ⤷  Sign Up 91252 Luxembourg ⤷  Sign Up
European Patent Office 0957929 ⤷  Sign Up 300234 Netherlands ⤷  Sign Up
European Patent Office 0957929 ⤷  Sign Up PA2006004 Lithuania ⤷  Sign Up
European Patent Office 0957929 ⤷  Sign Up CA 2006 00021 Denmark ⤷  Sign Up
European Patent Office 0957929 ⤷  Sign Up SPC024/2006 Ireland ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.